КЛІНІЧНА ЕФЕКТИВНІСТЬ ВИКОРИСТАННЯ КВЕРЦЕТИНУ У КОМПЛЕКСНОМУ ЛІКУВАННІ ДІТЕЙ,ХВОРИХ НА ПОЗАЛІКАРНЯНУ ПНЕВМОНІЮ.

Authors

  • О. Е. Fedortsiv
  • І. В. Chornomydz
  • N. B. Behosh

DOI:

https://doi.org/10.11603/24116-4944.2013.2.6658

Abstract

CLINICAL EFFICIENCY QUERCETIN IN COMPLEX TREATMENT OF CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA. 
The study invoived 128chiidren aged б to 14 years,patients with community-acquired pneumonia.The investigation of efficiency 
inciuded in the standard treatment regimen of the drug quercetin which is confirmed by rapid regression of the main ciinical manifestations 
of disease

 

References

AkynynaM.N.,KuznetsovS.V.Nekotorye voprosy dyahnostyky y terapyy khlamydyynykh pnevmony yude-tey// Mezhdunarodnyy medytsynskyy zhurnal.-200b.-№2.-s .117-119.

DennehyP.H.Respiratoryinfectionsinthenewborn// Ciin. Perinatoi. - 1987.-№.14.-P.bb7.

Klynycheskyerekomendatsyy.Pedyatryya(Pnevmonyya udetey)/Podred.A.A.Baranova.-M.:HÉOTAR-Medya, 2005.-28s.

UNICEF/WHO,Pneumonia:Theforgotte nkiiierof chiidren,200b.

WoridHeaithOrganization,WoridHeaithReport2005: MakeEveryMotherandChiidCount,WoridHeaithOrganization, Geneva,2005.

WoridHeaithOrganization,WoridHeaithStatistics200b, WoridHeaithOrganization,Geneva,200b.

TekhnycheskayabazadlyarekomendatsyyVOZpovede-nyyubolʹnykhpnevmonyeydetey.DokumentWHO/ARI/91/ 20,WHO,Geneva,1991.

MaydanykV.H.,SmiyanO.I.,ByndaT.P.Hostrapnev-moniyauditey:Klinichnivariantyperebihu,diahnostykata likuvannya:Navchalʹnyyposibnyk.-Sumy:Vyd-voSum-DU,2009.-15b

PetitG,DeWaisPetai.Epidemioiogicaiandeconomic

burdenofpneumococcaidiseasesinCanadianchiidren//Can JInfectDis.-2003.-№14(4).-R.215-220.

VolosovetsʹO.P.,YulishYE.I.Ratsionalʹnaantybio-tykoterapiyarespiratornykhzakhvoryuvanʹuditey.-Ternopilʹ: Ukrmedknyha,2003.-400s.

Det·skayapulʹmonolohiya/N.L.Aryaev,N.V.Kotova ydr..;Podred..N.L.Aryaeva.-K.:Zdorov'ya,2005.-b08s.

KostrominaV.P.,StryzhV.O.Pnevmoniyauditey:pryn-tsypystartovohokontrolʹovanoholikuvannya/ /Dytyachyy likar-2010.-№2.-S.5-11.

GendreiD.Pneumoniescommunautairesd ei'enfant: etioiogieettraitemen t//Arch.Pediatr.-2002.-№9(3).-R.278-288.

VatutinM.T.,HoncharenkoT.S.,SklyannaO.V.,Zakkha-maS.Flavonoyidkvertsetyn:farmakolohichnivlastyvosti taklinichnevykorystannya//Liky .-2005.-№3-4.-S.19-27.

KovalevV.B.,KovhanV.V.,KolchynaE.YU.Mekhanyz-mylechebnohodeystvyyabyoflavonoydakvertsetyna(obzor lyteratury)//Ukr.med.alʹmanakh.-1999.-T.2,№4.-S.17b-184.

Downloads

Published

2016-09-07

How to Cite

Fedortsiv О. Е., Chornomydz І. В., & Behosh, N. B. (2016). КЛІНІЧНА ЕФЕКТИВНІСТЬ ВИКОРИСТАННЯ КВЕРЦЕТИНУ У КОМПЛЕКСНОМУ ЛІКУВАННІ ДІТЕЙ,ХВОРИХ НА ПОЗАЛІКАРНЯНУ ПНЕВМОНІЮ. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2). https://doi.org/10.11603/24116-4944.2013.2.6658

Issue

No. 2 (2013)

Section

PEDIATRICS

License

Authors who publish in this journal agree to the following terms:

1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.

Результат пошуку зображень за запитом "CC-BY logo"

 2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.

3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).